Microbial sealant

Introducing a first-in-class microbial barrier designed to seal and immobilise bacteria.

Kimberly-Clark InteguSeal* microbial sealant helps protect against skin flora migration into surgical incisions

InteguSeal* microbial sealant locks down bacteria residing deep in the skin as well as those surviving typical pre-operative prepping.

  • Seals and immobilizes dangerous pathogens in the site of application, including MRSA, S.epidermis and E.coli
  • Breathable properties permit normal skin transpiration
  • Unique mechanism of action does not promote bacterial resistance

Surgical Site Infections result in up to $13 billion in costs every year1

Compared to uninfected patients, patients with an SSI2:

  • Stay hospitalized seven days longer
  • Are sixty percent more likely to spend time in the intensive care unit
  • Are five times more likely to be readmitted within 30 days of discharge
  • Have twice the mortality rate3

Coverage for a range of surgical applications

InteguSeal* microbial sealant is available in three sizes:

  • 33730 – Model IS50 provides about 12 cm × 25 cm coverage.
  • 33736 – Model IS100 provides about 25 cm × 25 cm coverage.
  • 33737 – Model IS200 provides about 50 cm × 25 cm coverage.

Kimberly-Clark InteguSeal* microbial sealant is just one of the clinical solutions you can trust to meet the demands of your fast-paced world.

Whether your needs involve preventing healthcare-associated infections or surgical and digestive solutions, with Kimberly-Clark you’ll always have one less worry.

More information

These products are available from a wide range of distributors.

For more information regarding our products call our Customer Care line 1800 101 021, or email hccusto@kcc.com.

  1. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections, in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999 Nov;20(11):K725-30.
  2. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara ED, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Die. 2003;9(2): 196-203.
  3. Data on file, Kimberly-Clark Health Care.

The products listed in this directory have been introduced specifically for healthcare providers in Australia and New Zealand. Additional information is available on the United States based Kimberly-Clark Health Care website.

Kimberly-Clark makes no representation that its products described in this website will provide complete protection from exposure to contaminants, fluids, or micro organisms or will eliminate the risk of contracting infectious diseases.